» Articles » PMID: 29562535

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2018 Mar 23
PMID 29562535
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegeneration is defined as the progressive loss of structure or function of the neurons. As the nature of degenerative cell loss is currently not clear, there is no specific molecular marker to measure neurodegeneration. Therefore, researchers have been using apoptotic markers to measure neurodegeneration. However, neurodegeneration is completely different from apoptosis by morphology and time course. Lacking specific molecular marker has been the major hindrance in research of neurodegenerative disorders. Alzheimer's disease (AD) is the most common neurodegenerative disorder, and tau accumulation forming neurofibrillary tangles is a hallmark pathology in the AD brains, suggesting that tau must play a critical role in AD neurodegeneration. Here we review part of our published papers on tau-related studies, and share our thoughts on the nature of tau-associated neurodegeneration in AD.

Citing Articles

Updates in Alzheimer's disease: from basic research to diagnosis and therapies.

Liu E, Zhang Y, Wang J Transl Neurodegener. 2024; 13(1):45.

PMID: 39232848 PMC: 11373277. DOI: 10.1186/s40035-024-00432-x.


Targeting autophagy in Alzheimer's disease: Animal models and mechanisms.

Zhang X, Zhu X, Tang D, Lu J Zool Res. 2023; 44(6):1132-1145.

PMID: 37963840 PMC: 10802106. DOI: 10.24272/j.issn.2095-8137.2023.294.


Editorial: Anesthetic-induced neurotoxicity and neurocognitive impairment of vulnerable brains.

Zeng S, Zhang J Front Aging Neurosci. 2023; 15:1293491.

PMID: 37885899 PMC: 10598338. DOI: 10.3389/fnagi.2023.1293491.


Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.

Alkahtani S, Al-Johani N, Alarifi S Int J Mol Sci. 2023; 24(2).

PMID: 36674852 PMC: 9865061. DOI: 10.3390/ijms24021340.


Roles for c-Abl in postoperative neurodegeneration.

Feng L, Fu S, Yao Y, Li Y, Xu L, Zhao Y Int J Med Sci. 2022; 19(12):1753-1761.

PMID: 36313229 PMC: 9608039. DOI: 10.7150/ijms.73740.


References
1.
Zhang Z, Obianyo O, Dall E, Du Y, Fu H, Liu X . Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease. Nat Commun. 2017; 8:14740. PMC: 5378956. DOI: 10.1038/ncomms14740. View

2.
Xia Y, Liu R, Chen R, Tian Q, Zeng K, Hu J . Novel multipotent AChEI-CCB attenuates hyperhomocysteinemia-induced memory deficits and Neuropathologies in rats. J Alzheimers Dis. 2014; 42(3):1029-39. DOI: 10.3233/JAD-140597. View

3.
Luo D, Feng Q, Wang Z, Sun D, Wang Q, Wang J . Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation. J Neurochem. 2014; 130(6):816-25. DOI: 10.1111/jnc.12761. View

4.
Zhang S, Li X, Wang Z, Liu Y, Gao Y, Tan L . Paternal spatial training enhances offspring's cognitive performance and synaptic plasticity in wild-type but not improve memory deficit in Alzheimer's mice. Sci Rep. 2017; 7(1):1521. PMC: 5431522. DOI: 10.1038/s41598-017-01811-3. View

5.
Li X, Lv B, Xie J, Liu J, Zhou X, Wang J . AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging. 2011; 33(7):1400-10. DOI: 10.1016/j.neurobiolaging.2011.02.003. View